Cleared Traditional

Altaviz Needle Kit (K222681) - FDA 510(k) Clearance

Class II General Hospital device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K222681 · Altaviz, LLC · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2022
Decision
90d
Days
Class 2
Risk

K222681 is an FDA 510(k) clearance for the Altaviz Needle Kit. Classified as Needle, Hypodermic, Single Lumen (product code FMI), Class II - Special Controls.

Submitted by Altaviz, LLC (Irvine, US). The FDA issued a Cleared decision on December 5, 2022 after a review of 90 days - within the typical 510(k) review window.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5570 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Altaviz, LLC devices

Submission Details

510(k) Number K222681 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 06, 2022
Decision Date December 05, 2022
Days to Decision 90 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
39d faster than avg
Panel avg: 129d · This submission: 90d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FMI Needle, Hypodermic, Single Lumen
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5570
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Consultant

Allied Regulatory Consulting
Sean Griffin

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - FMI Needle, Hypodermic, Single Lumen

All 196
Devices cleared under the same product code (FMI) and FDA review panel - the closest regulatory comparables to K222681.
BD AutoShield Duo™ Pen Needle
K223286 · Becton, Dickinson and Company · Dec 2022
Sterile Hypodermic Needles for Single Use
K223334 · Zhejiang Kindly Medical Devices Co., Ltd. · Dec 2022
CCBIO ASCPO Needle
K214004 · Cc Biotechnology Corporation · Dec 2022
DropSafeTM SicuraTM
K223353 · Pikdare Spa · Dec 2022
Disposable Insulin Pen Needle
K221178 · Ningbo Medsun Medical Co., Ltd. · Nov 2022
Sterile Hypodermic Syringe with/without Needle, Hypodermic Needle
K222124 · Anhui Hongyu Wuzhou Medical Manufacturer Co., Ltd. · Nov 2022